ODC1 and breast carcinoma: Co‐administration of difluoromethylornithine (DFMO), a specific inhibitor for ODC1[35] also significantly blocked paclitaxel‐induced enrichment of ALDH+ cells in breast cancer cells (Figure S2M, Supporting Information).